Literature DB >> 30105613

Correlation of serum levels and gene expression of tumor necrosis factor-α-induced protein-8 like-2 with Parkinson disease severity.

Ebrahim Kouchaki1, Reza Daneshvar Kakhaki1, Omid Reza Tamtaji2,3, Ehsan Dadgostar4, Mohammad Behnam5, Alireza Zaribaf5, Hassan Nikoueinejad6,7, Hossein Akbari8, Zatollah Asemi9.   

Abstract

Different immune-mediated mechanisms involved in the pathogenesis of Parkinson disease (PD) as a neurodegenerative and inflammatory disease. According to our knowledge, there is no report evaluating Tumor necrosis factor-α-induced protein-8 like-2 (TIPE2), a cytokine maintaining immune homeostasis, in PD. We analyzed the correlation of the serum levels and circulatory gene expression of TIPE2 with severity of PD. In this case-control study, 43 patients with PD and 40 healthy subjects were enrolled. The diagnosis of PD was performed byclinical diagnostic criteria of the UK Parkinson's Disease Society Brain Bank. The severity of PD was evaluated by modified Hoehn and Yahr (H and Y) scale. Serum levels and gene expression of TIPE2 were assessed by Elisa and real time PCR, respectively. The mean serum levels and gene expression of TIPE2 in patients with PD did not have significant difference compared to healthy subjects. Linear multiple regression analysis showed that increased serum levels of TIPE2 are positively related to age and severity of PD (P ≤ 0.0001). In addition, the gene expression of TIPE2 was found to be associated with age (P < 0.0001). Our study showed that the serum levels of TIPE2 and its gene expression might be important prognostic biomarkers of PD.

Entities:  

Keywords:  Gene expression; Parkinson disease; TIPE2; TNFAIP8

Mesh:

Substances:

Year:  2018        PMID: 30105613     DOI: 10.1007/s11011-018-0302-7

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  29 in total

1.  Serum inflammatory biomarkers in Parkinson's disease.

Authors:  M Dufek; M Hamanová; J Lokaj; D Goldemund; I Rektorová; Z Michálková; K Sheardová; I Rektor
Journal:  Parkinsonism Relat Disord       Date:  2008-07-30       Impact factor: 4.891

2.  Tissue-specific expression of TIPE2 provides insights into its function.

Authors:  Guizhong Zhang; Chunyan Hao; Yunwei Lou; Wenjin Xi; Xuping Wang; Yan Wang; Zhonghua Qu; Chun Guo; Youhai Chen; Yun Zhang; Suxia Liu
Journal:  Mol Immunol       Date:  2010-07-21       Impact factor: 4.407

3.  TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis.

Authors:  Honghong Sun; Shunyou Gong; Ruaidhri J Carmody; Anja Hilliard; Li Li; Jing Sun; Li Kong; Lingyun Xu; Brendan Hilliard; Shimin Hu; Hao Shen; Xiaolu Yang; Youhai H Chen
Journal:  Cell       Date:  2008-05-02       Impact factor: 41.582

4.  TIPE2 controls innate immunity to RNA by targeting the phosphatidylinositol 3-kinase-Rac pathway.

Authors:  Honghong Sun; Guohong Zhuang; Lihui Chai; Zhaojun Wang; Derek Johnson; Yuanfang Ma; Youhai H Chen
Journal:  J Immunol       Date:  2012-08-17       Impact factor: 5.422

5.  Increased serum levels of soluble tumor necrosis factor-alpha receptor-1 in patients with Parkinson's disease.

Authors:  Paula Scalzo; Arthur Kümmer; Francisco Cardoso; Antônio Lúcio Teixeira
Journal:  J Neuroimmunol       Date:  2009-09-03       Impact factor: 3.478

6.  Down-regulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.

Authors:  Di Li; Lijun Song; Yuchen Fan; Xia Li; Yingjie Li; Jie Chen; Faliang Zhu; Chun Guo; Yongyu Shi; Lining Zhang
Journal:  Clin Immunol       Date:  2009-09-12       Impact factor: 3.969

7.  Anti-inflammatory TIPE2 inhibits angiogenic VEGF in retinal pigment epithelium.

Authors:  Ling-Ge Suo; Yan-Yan Cui; Ye Bai; Xue-Jiao Qin
Journal:  Mol Immunol       Date:  2016-04-01       Impact factor: 4.407

8.  Increased CSF biomarkers of angiogenesis in Parkinson disease.

Authors:  Shorena Janelidze; Daniel Lindqvist; Veronica Francardo; Sara Hall; Henrik Zetterberg; Kaj Blennow; Charles H Adler; Thomas G Beach; Geidy E Serrano; Danielle van Westen; Elisabet Londos; M Angela Cenci; Oskar Hansson
Journal:  Neurology       Date:  2015-10-28       Impact factor: 9.910

9.  Whole-exome sequencing associates novel CSMD1 gene mutations with familial Parkinson disease.

Authors:  Javier Ruiz-Martínez; Luis J Azcona; Alberto Bergareche; Jose F Martí-Massó; Coro Paisán-Ruiz
Journal:  Neurol Genet       Date:  2017-08-02

10.  Human tumor necrosis factor (TNF)-alpha-induced protein 8-like 2 suppresses hepatocellular carcinoma metastasis through inhibiting Rac1.

Authors:  Xuelei Cao; Li Zhang; Yongyu Shi; Yue Sun; Shen Dai; Chun Guo; Faliang Zhu; Qun Wang; Jianing Wang; Xiaoyan Wang; Youhai H Chen; Lining Zhang
Journal:  Mol Cancer       Date:  2013-11-26       Impact factor: 27.401

View more
  7 in total

Review 1.  Can Berberine Serve as a New Therapy for Parkinson's Disease?

Authors:  Ehsan Dadgostar; Mahsa Moghanlou; Mehrnoosh Parvaresh; Salimeh Mohammadi; Mohammadali Khandan; Michael Aschner; Hamed Mirzaei; Omid Reza Tamtaji
Journal:  Neurotox Res       Date:  2022-06-06       Impact factor: 3.978

Review 2.  Probiotics and the Treatment of Parkinson's Disease: An Update.

Authors:  Hamed Mirzaei; Saman Sedighi; Ebrahim Kouchaki; Erfaneh Barati; Ehsan Dadgostar; Michael Aschner; Omid Reza Tamtaji
Journal:  Cell Mol Neurobiol       Date:  2021-07-20       Impact factor: 4.231

3.  The Association between Toxoplasma gondii Infection and Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis.

Authors:  Zonglei Zhou; Ruzhen Zhou; Kunpeng Li; Wen Wei; Zengqiao Zhang; Yan Zhu; Rongsheng Luan
Journal:  Biomed Res Int       Date:  2019-02-25       Impact factor: 3.411

4.  Urinary Dysfunction Is Associated with Nigrostriatal Dopaminergic Degeneration in Early and Untreated Patients with Parkinson's Disease.

Authors:  Jing Wang; Ruihua Cao; Tao Huang; Cheng Liu; Yidong Fan
Journal:  Parkinsons Dis       Date:  2020-11-28

5.  Increased PRR14 and VCAM-1 level in serum of patients with Parkinson's disease.

Authors:  Huimin Zheng; Tai Wang; Changhe Shi; Liyuan Fan; Yun Su; Yu Fan; Xinwei Li; Jing Yang; Chengyuan Mao; Yuming Xu
Journal:  Front Neurol       Date:  2022-09-30       Impact factor: 4.086

Review 6.  TIPE Family of Proteins and Its Implications in Different Chronic Diseases.

Authors:  Devivasha Bordoloi; Kishore Banik; Bano Shabnam; Ganesan Padmavathi; Javadi Monisha; Frank Arfuso; Arunasalam Dharmarajan; Xinliang Mao; Lina H K Lim; Lingzhi Wang; Lu Fan; Kam Man Hui; Alan Prem Kumar; Gautam Sethi; Ajaikumar B Kunnumakkara
Journal:  Int J Mol Sci       Date:  2018-09-29       Impact factor: 5.923

Review 7.  Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer's and Parkinson's Diseases.

Authors:  Sonia Mayo; Julián Benito-León; Carmen Peña-Bautista; Miguel Baquero; Consuelo Cháfer-Pericás
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.